* CareMax Inc CMAX.OQ CMAX.O is expected to show a rise
in
quarterly revenue when it reports results on August 9.
* The Miami Florida-based company is expected to report a
9.2% increase in revenue to $188.11 million from $172.28 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for CareMax Inc is for
a loss
of 7 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for CareMax Inc
is
$5, above its last closing price of $2.71.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.15 -0.14 -0.74 Missed -410.3
Dec. 31 2023 -0.05 -0.05 0.79 Beat 1,680
Sep. 30 2022 -0.07 -0.06 -0.25 Missed -290.6
Jun. 30 2022 -0.05 -0.05 -0.11 Missed -106.3
Mar. -0.02 -0.02 -0.19 Missed -660
31 2022
Dec. 31 2021 -0.06 -0.06 -0.04 Beat 33.3
Sep. 30 2021 -0.08 -0.08 -0.03 Beat 63.6
Jun. 30 2021 -0.04 -0.04 -0.26 Missed -550
This summary was machine generated August 7 at 18:21 GMT. All
figures in US dollars unless otherwise stated